GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Serina Therapeutics Inc (AMEX:SER) » Definitions » Common Stock

Serina Therapeutics (Serina Therapeutics) Common Stock : $0.00 Mil (As of Mar. 2024)


View and export this data going back to 2024. Start your Free Trial

What is Serina Therapeutics Common Stock?

Serina Therapeutics's quarterly common stock stayed the same from Dec. 2022 ($0.02 Mil) to Jun. 2023 ($0.02 Mil) but then declined from Jun. 2023 ($0.02 Mil) to Mar. 2024 ($0.00 Mil).

Serina Therapeutics's annual common stock increased from . 20 ($0.00 Mil) to Dec. 2021 ($0.02 Mil) and increased from Dec. 2021 ($0.02 Mil) to Dec. 2022 ($0.02 Mil).


Serina Therapeutics Common Stock Historical Data

The historical data trend for Serina Therapeutics's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Serina Therapeutics Common Stock Chart

Serina Therapeutics Annual Data
Trend Dec21 Dec22
Common Stock
0.02 0.02

Serina Therapeutics Semi-Annual Data
Dec21 Jun22 Dec22 Jun23 Mar24
Common Stock 0.02 - 0.02 0.02 -

Serina Therapeutics Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.


Serina Therapeutics (Serina Therapeutics) Business Description

Comparable Companies
Traded in Other Exchanges
Address
601 Genome Way, Suite 2001, Huntsville, AL, USA, 35806
Serina Therapeutics Inc is a clinical-stage biotechnology company developing a pipeline of wholly-owned drug product candidates to treat neurological diseases and pain. Serina's POZ Platform delivery technology is engineered to provide control in drug loading and more precision in the rate of release of attached drugs, enabling the potential of certain challenging small molecules, while addressing the limitations of polyethylene glycol (PEG) and other biocompatible polymers.

Serina Therapeutics (Serina Therapeutics) Headlines